Fig. 4

Goodness-of-fit diagnostic plots of the final model for pediatric patients with B-cell precursor acute lymphoblastic leukemia (ALL). Log observed inotuzumab ozogamicin concentration versus a population prediction and b individual prediction. The solid lines show the reference line (y = x). c Scatter plots of conditional weighted residuals against population prediction and d time after each dose